AllStripes Raises $50 million to support rare disease research
AllStripes recently closed a $50 million Series B funding round led by Lux Capital, with participation from McKesson Ventures, JAZZ Venture Partners, Spark Capital, Medidata Solutions (a Dassault Systèmes company), and Maveron, along with angel investors including Arif Nathoo, CEO of McKesson Ventures portfolio company Komodo Health; and Leila Zegna, director of the Kabuki Syndrome Foundation. AllStripes, formerly known as RDMD was founded in 2017 by Nancy Yu, who had previously been in corporate development for 23andMe; and Onno Faber, a developer who was diagnosed with...